We are live on
!
Find out more
JAM
JW Asset Management Portfolio holdings
AUM
$320M
1-Year Est. Return
140.1%
This Fund
S&P 500
This Quarter
Est. Return
-14.4%
1 Year Est. Return
+140.1%
3 Year Est. Return
+250.82%
5 Year Est. Return
+197.91%
10 Year Est. Return
+3,970.08%
AUM
$175M
AUM Growth
-$55.7M
(-24%)
Cap. Flow
+$9.09M
Cap. Flow
% of AUM
5.19%
Top 10 Holdings %
Top 10 Hldgs %
95.36%
Holding
19
New
4
Increased
3
Reduced
2
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AdvisorShares Pure US Cannabis ETF
MSOS
|
+$4.66M |
| 2 |
NVIDIA
NVDA
|
+$4.46M |
| 3 |
Abercrombie & Fitch
ANF
|
+$2.49M |
| 4 |
Snap
SNAP
|
+$2.08M |
| 5 |
Amplify Alternative Harvest ETF
MJ
|
+$400K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$2.63M |
| 2 |
CPRX
Catalyst Pharmaceutical
CPRX
|
+$2.05M |
| 3 |
CRON
Cronos Group
CRON
|
+$400K |
| 4 |
Heron Therapeutics
HRTX
|
+$127K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 69.43% |
| 2 | Consumer Staples | 14.49% |
| 3 | Technology | 6.96% |
| 4 | Miscellaneous | 3.04% |
| 5 | Communication Services | 1.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Establishment Labs
ESTA
$2.11B
| $82.7M | 47.18% |
3,192,485
| – | – |
|
2
Celsius Holdings
CELH
$6.89B
| $16.5M | 9.43% |
303,000
+3,000
| +1% | +$160K |
|
3
Eli Lilly
LLY
$994B
| $15.7M | 8.98% |
27,000
| – | – |
|
|
NVO
4
Novo Nordisk
NVO
$190B
| $12.2M | 6.98% |
118,200
| – | – |
|
|
5
NVIDIA
NVDA
$5.27T
| $12.2M | 6.96% |
246,250
+96,250
| +64% | +$4.46M |
|
6
Vita Coco
COCO
$3.01B
| $8.87M | 5.06% |
345,621
| – | – |
|
|
CPRX
7
DELISTED
Catalyst Pharmaceutical
CPRX
| $6.95M | 3.97% |
413,392
-150,000
| -27% | -$2.05M |
|
|
8
AdvisorShares Pure US Cannabis ETF
MSOS
$936M
| $4.91M | 2.81% |
+701,002
| New | +$4.66M |
|
|
9
Heron Therapeutics
HRTX
$59.9M
| $3.9M | 2.22% |
2,292,418
-115,000
| -5% | -$127K |
|
|
10
Abercrombie & Fitch
ANF
$6.16B
| $3.09M | 1.76% |
+35,000
| New | +$2.49M |
|
|
11
Snap
SNAP
$9.61B
| $2.88M | 1.64% |
+170,000
| New | +$2.08M |
|
12
Idaho Strategic Resources
IDR
$489M
| $1.72M | 0.98% |
271,697
| – | – |
|
13
Eaton
ETN
$165B
| $1.2M | 0.69% |
5,000
| – | – |
|
14
Caterpillar
CAT
$376B
| $1.19M | 0.68% |
4,024
| – | – |
|
|
FAZE
15
DELISTED
FaZe Holdings Inc. Common Stock
FAZE
| $563K | 0.32% |
3,126,319
| – | – |
|
|
16
Amplify Alternative Harvest ETF
MJ
$110M
| $413K | 0.24% |
+10,650
| New | +$400K |
|
|
HITI
17
High Tide
HITI
$222M
| $166K | 0.1% |
102,144
+27,144
| +36% | +$41K |
|
|
CRON
18
Cronos Group
CRON
$1.16B
| – | – |
-200,000
| Closed | -$400K |
|
|
19
Tesla
TSLA
$1.44T
| – | – |
-10,500
| Closed | -$2.63M |
|
Similar funds
PCM
IP
PCM
LJCM
GTAM
SIC
AFS
BMCM
JW Asset Management's Q4 2023 Portfolio in Review
As of Q4 2023, JW Asset Management held 19 positions worth $175M, down 24% from $231M the previous quarter. Its ten largest holdings account for 95% of the portfolio.
JW Asset Management deployed $9.09M of net new capital in Q4 2023, opening 4 new positions and adding to 3 existing holdings. Its largest new stake was AdvisorShares Pure US Cannabis ETF: 701,002 shares worth $4.91M.
By sector, the portfolio is most concentrated in Healthcare at 69% of assets, down from 83% a quarter earlier, followed by Consumer Staples and Technology.
On the sell side, the largest reduction was Catalyst Pharmaceutical, an estimated $2.05M trimmed.
- JW Asset Management's largest Q4 2023 buy was AdvisorShares Pure US Cannabis ETF: 701,002 shares worth $4.91M.
- JW Asset Management added most to NVIDIA in Q4 2023, an estimated $4.46M increase.
- JW Asset Management's biggest Q4 2023 reduction was Catalyst Pharmaceutical, cutting an estimated $2.05M.
- JW Asset Management fully exited Tesla in Q4 2023, selling an estimated $2.63M.
- JW Asset Management's ten largest holdings make up 95% of its $175M portfolio in Q4 2023.
- JW Asset Management opened 4 new positions and closed 2 in Q4 2023.
- JW Asset Management's portfolio value fell 24% quarter-over-quarter to $175M.
Based on JW Asset Management's 13F filing for Q4 2023, filed 9 Feb 2024.